BioSpace News Archive

Business

bluebird bio Reports Second Quarter 2023 Financial Results and Highlights Operational Progress

bluebird bio, Inc. (NASDAQ: BLUE) (“bluebird bio” or the “Company”) today reported financial results and business highlights for the second quarter ended June 30, 2023, including recent commercial and operational progress, and regulatory updates.

August 8, 2023
·
12 min read
Business

Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates

Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading microbiome therapeutics company, today reported second quarter 2023 financial results and provided business updates.

August 8, 2023
·
19 min read
Business

Novanta Announces Financial Results for the Second Quarter 2023

Novanta Inc. today reported financial results for the second quarter 2023.

August 8, 2023
·
29 min read
Business

Verrica Pharmaceuticals Reports Second Quarter 2023 Financial Results

Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced financial results for the second quarter ended June 30, 2023.

August 8, 2023
·
13 min read
Business

Freeline Therapeutics to Host Second Quarter 2023 Financial Results Call

Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Tuesday, August 15, 2023 to report its second quarter financial results and provide a corporate update.

August 8, 2023
·
1 min read
Business

Abeona Therapeutics Reports Second Quarter 2023 Financial Results

Abeona Therapeutics Inc. (Nasdaq: ABEO) today reported financial results for the second quarter of 2023 and provided an update on progress toward achieving key corporate objectives.

August 8, 2023
·
9 min read
Business

Organon Reports Results for the Second Quarter Ended June 30, 2023

Organon (NYSE: OGN) today announced its results for the second quarter ended June 30, 2023.

August 8, 2023
·
21 min read
Genetown

Revolo Biotherapeutics to Host Virtual KOL Event on ‘1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease

Revolo Biotherapeutics (“Revolo” or the “Company”) today announced it will host a virtual KOL event on ‘1104, a first-in-class peptide for eosinophilic esophagitis (EoE) and allergen sensitivity on Tuesday, August 29, 2023, at 11:00 AM – noon ET.

August 8, 2023
·
4 min read
Business

ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS

Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023.

August 8, 2023
·
34 min read
Baylor College of Medicine Human Genome Sequencing Center adopts Olink® Explore HT proteomics platform

Olink Holding AB announced that the Baylor College of Medicine Human Genome Sequencing Center has selected the Olink Explore platform as a proteomics component of their world-class multiomics offering.

August 8, 2023
·
4 min read